Anti-Platelet Agents Market
Anti-Platelet Agents Market Analysis by Aspirin, Clopidogrel, Ticagrelor, Prasugrel, and Others Sold through Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others from 2023 to 2033
Analysis of Anti-Platelet Agents Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Anti-Platelet Agents Market Outlook (2023 to 2033)
The global anti-platelet agents market is valued at US$ 2.4 billion in 2023 and is forecasted to expand at a CAGR of 7% during the study period of 2023 to 2033. As such, global demand for anti-platelet agents is projected to reach a market valuation of US$ 4.8 billion by the end of 2033.
Anti-platelet medications or agents are incorrectly referred to as ‘blood thinners’. They are used at a significant rate for the prevention of blood clots. They work by preventing some hazardous clots from sticking together.
As per this detailed study conducted on the global market, anti-platelet medications have been used to provide treatment to patients who are undergoing some difficult surgical operations, for instance, angioplasty. In addition, fast-changing lifestyles are leading to the rising prevalence of cardiovascular diseases.
- The World Health Organization (WHO) has provided some estimations. According to that around 15 million people around the world die every year from heart conditions, for example, heart strokes.
Rising cardiovascular issues are further estimated to fuel demand for anti-platelet agents to ensure effective healthcare solutions for people. These anti-platelet agents prevent clotting by restricting the activity of the platelet to bind or stick together. Furthermore, clotting of blood is generally a physiological reaction of the human body that assists in controlling any sort of external bleeding at the time of injury.
Blood clotting within blood vessels can cause some serious complications as they restrict the flow of blood. As a result, different anti-platelet medications are prescribed as therapeutic solutions to stop blood clotting as feasible and quick solutions.
Rising aging population is also one of the pivotal factors that generate lucrative opportunities owing to their weaker immune system, which can cause serious health issues. In addition, due to their age, these people are prone to various heart issues and thus contributing to increased demand for anti-platelet agents.
The proliferation of anticoagulant or antithrombotic drugs can aid in the rising demand for anti-platelet agents during the forecast period. Surging thrombotic events are also predicted to fuel demand for anti-platelet agents in the coming years. In recent years, various technological advancements are taking place around the world intending to improve the efficiencies of anti-platelet agents and can help industry players to acquire substantial revenue in the forecasted period.
Report Attributes |
Details |
|
Anti-Platelet Agents Market Size in 2023 |
US$ 2.4 Billion |
|
Projected Market Value (2033) |
US$ 4.8 Billion |
|
Estimated Market Growth Rate (2023 to 2033) |
7% CAGR |
|
Canada Market Growth Rate (2023 to 2033) |
6.2% CAGR |
|
Germany Market Growth Rate (2023 to 2033) |
4.4% CAGR |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is Demand for Anti-Platelet Agents Increasing at a Fast Pace?
“Rising Worldwide Prevalence of Cardiovascular Diseases”
Growing cases of cardiovascular diseases are propelling demand for anti-platelet agents. Not only in developing but also in developed economies, cardiovascular disorders are one of the leading causes of death.
- More than 800,000 people in the United States every year die due to stroke and some other cardiovascular disorders, as per the information provided by the Centers for Disease Control and Prevention (CDC).
- In the year 2020, around 3,658 heart transplantation procedures had been performed in the United States. Some of the noticeable incidences of heart transplantations include the states of California (496), Texas (302), Florida (288), and New York (250).
“Increasing Investments in Healthcare Infrastructure Development”
Countries around the world are investing at an increased rate in healthcare, which further helps to improve respective facilities. In addition, public as well as private organizations, across the globe are taking initiatives to spread awareness about myriad fungal infections that can be treated with the use of anti-platelet agents.
A sedentary lifestyle of individuals can result in increased health disorders. Moreover, the rising population of geriatric people can also propel the demand for anti-platelet agents owing to their cardiovascular issues. The increasing thrombotic events will also fuel demand for anti-platelet agents in the coming years.
“Increasing Number of Research & Development Activities”
Key manufacturers of anti-platelet agents are involved in various research & development activities that can further generate beneficial opportunities for them.
For instance :
- PhasBio Pharmaceuticals, Inc. is a biopharmaceutical company. In April 2022, it announced the comprehensive results from its Phase 2b clinical trial of bentracimab. It was presented on April 2, 2022, at the 71st Annual Scientific Session at the American College of Cardiology during a Late Breaking Featured Clinical Research Presentation.
Bentracimab is designed for the reversal of the antiplatelet activity of ticagrelor among patients who need surgery or experiencing uncontrolled bleeding.
How Can Sales of Anti-Platelet Agents Be Adversely Affected?
“Side Effects and Comparatively High Cost of Anti-Platelet Agents”
The cost of anti-platelet agents is comparatively higher. Thus, the easy availability of these agents for everyone becomes a bit difficult. In addition, there are a few side effects that are related to the consumption of anti-platelet agents and can put adverse impacts on their demand.
“Lack of Healthcare Facilities in Developing Economies”
Developing economies around the world are not well-equipped with advanced healthcare infrastructure or facilities. There is a lack of advanced and well-established healthcare facilities there. In addition, limitations in the safety and efficacy of some anti-platelet drugs can also challenge their demand.
Which Region is Estimated to Emerge as a Lucrative Market for Anti-Platelet Agent Suppliers?
“Adoption of Advanced Healthcare Technologies in North America”
North America holds a dominating position in the global market owing to the rising adoption of new and advanced healthcare technologies. Furthermore, the growing demand for disease-specific treatment is also predicted to generate revenue.
North America is considered the hub of prominent suppliers who are penetrating the region at a significant rate. They are investing at a significant rate in various R&D activities and in clinical trials that are related to anti-platelet agents.
A significant number of patients in North America are suffering from ischaemic strokes and myocardial infarction that require anti-platelet agents for their treatment.
For instance :
- Around 800,000 people in the United States suffer from stroke each year. Among these, around 87% are ischaemic strokes.
Asia Pacific is also projected to experience substantial growth in the coming years due to the growing investments by players in different R&D activities. Further, rising government initiatives to minimize the count of deaths, which are caused by thrombotic cardiovascular disease are also contributing to product demand.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
What is the Stance of Japan for Anti-Platelet Agents?
“Increased Investments in R&D Activities”
Sales of anti-platelet agents in Japan are expected to expand at a moderate CAGR of 3.7% through 2033. The government of Japan is spending at a significant rate on R&D activities. These research activities will help Japan to reduce the number of deaths that are caused due to thrombotic cardiovascular disease.
How Can Anti-Platelet Agents Manufacturers Benefit in the United States?
“Growing Cases of Ischaemic Strokes and Myocardial Infarction”
In recent years, there is a significant increase in the count of people who are suffering from ischaemic strokes as well as myocardial infarction. Thus, there arises a crucial requirement for anti-platelet agents. In addition, some of the prominent players, which are operating in the United States can also help the country to gain traction in the regional market.
Demand for anti-platelet agents in the United States was more than US$ 550 million in 2022-end. Moreover, Sales of anti-platelet agents in Canada are predicted to advance at a high CAGR of 6.2% during the forecast period from 2023 to 2033.
Why is There Increasing Demand for Anti-Platelet Agents in Germany?
“Rapid Development of Healthcare Infrastructure”
The value of anti-platelet agents in Germany is anticipated to progress at a steady CAGR of 4.4% from 2023 to 2033. The healthcare infrastructure of Germany has been undergoing significant development in recent years. In addition, rising government initiatives to increase awareness about myocardial infarction are further contributing to increased demand for anti-platelet agents.
Category-wise Insights
Which Distribution Channel is Estimated to Lead Revenue Generation?
“Retail Pharmacies to Generate Substantial Revenue for Market Players”
Key segments based on distribution channels, including hospital pharmacies, online pharmacies, retail pharmacies, and others are analyzed in the recently published research report by Fact.MR, a provider of market research and competitive intelligence. Considering the post-pandemic scenarios, the retail pharmacies segment is estimated to expand at a revised CAGR of 7.1% during the forecast period from 2023 to 2033.
Further, the hospital pharmacies segment is estimated to progress at a CAGR of 7% through 2033 while reaching a valuation of US$ 1.7 billion by the end of 2033.
Competitive Landscape
Industry players are investing at a significant rate in new developments. These players are concentrating to strengthen the supply chain management system and providing quality products to end users. In the respective manufacturing process, they adhere to imposed rules and regulations that are set for quality control of end products and causing minimal environmental impacts.
These players are adopting numerous strategies, including merger & acquisition, approvals, partnerships, and others to generate untapped opportunities.
For instance :
- Alfasigma in June 2021 announced that it has received approval for the European license, which was for bentracimab from PhaseBio. Further, Bentracimab is a new human monoclonal antibody fragment. It has been designed for the reversal of the anti-platelet effects of Brilique/Brillinta in clinical tests.
Key suppliers of anti-platelet agents are Aspen, The Medicines Company, Sanofi, Pfizer, Johnson & Johnson, Daiichi Sankyo, Bristol-Myers Squibb, and Otsuka.
Segmentation of Anti-Platelet Agents Industry Research
-
By Drug :
- Aspirin
- Clopidogrel
- Ticagrelor
- Prasugrel
- Others
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
-
By Application :
- Angioplasty
- Percutaneous Coronary Interventions
- Myocardial Infraction
- Dental Surgeries
- Arterial Thrombosis
-
By End User :
- Ambulatory Surgical Centers
- Hospitals
- Emergency Service Centers
- Clinics
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Key Findings 1.1.1. Overall Market 1.1.2. Segment Overview 1.1.3. Regional Overview 1.1.4. Competitor’s Focus 1.1.5. Consumer’s Perception 1.2. Summary of Statistics 1.3. Market Characteristics and Attributes 2. Market Overview 2.1. Introduction and Definition 2.2. Research Scope 3. COVID 19 Impact Assessment 3.1. Demand in Market 3.1.1. Global Market Quarterly Market Value Analysis (US$ Mn), 2022 3.1.2. Global Market Value Y-o-Y Growth Pre and Post Crisis Projection 3.1.3. Global Market Recalibrated Growth Projection (US$ Mn) 3.2. Market Shrink and Recovery Trend Assessment, by Region 3.3. Market Recalibrated Market and Growth Assessment, by Region 4. Market Background 4.1. Country wise Market Attractiveness Index 4.2. Market Scenario-based Forecast 4.3. Value Chain Analysis 4.3.1. List of Manufacturers 4.3.2. List of Online Retailers 4.3.3. List of End Users 4.4. Investment Feasibility Assessment 4.4.1. Investment Feasibility for Market 4.5. Porter’s Five Forces Analysis 4.5.1. Bargaining Power of Buyers 4.5.2. Bargaining Power of Suppliers 4.5.3. Threat of Substitute Distribution Channels 4.5.4. Threat of New Entrants 4.5.5. Intensity of Rivalry 4.5.6. 5 Forces Acting Upon Market 4.6. PESTEL Analysis 4.7. Forecast Factors 4.7.1. Increasing Government Regulations 4.7.2. Expansion of Industry 4.7.3. Compliance to Insurance Regulations 4.7.4. Advancements in Market 4.7.5. Increasing Global Temperature 4.7.6. Technological Advancements 4.8. Market Dynamics 4.8.1. Market Drivers 4.8.2. Market Restraints 4.8.3. Opportunity Windows 4.8.4. Key Trends 5. Global Market Pricing Analysis 5.1. Price Point Assessment 5.1.1. Weighted Average Pricing (2022), by Region 5.1.2. Key Factors Influencing Pricing 5.1.3. Price Benchmark by Region 5.1.4. Price Benchmark by Drug 6. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033) 6.1. Market Overview 6.2. Introduction to Market Statistics 6.2.1. Global Market Volume (Units) 6.2.2. Global Market Value (US$ Mn) 6.2.3. Global Cumulative Historical Market and Absolute $ Opportunity 6.3. Y-o-Y Growth and Incremental Opportunity 6.4. Absolute Dollar Historical Market and Absolute Dollar Opportunity 7. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Drug 7.1. Introduction 7.1.1. Drug Definition 7.1.1.1. Aspirin 7.1.1.2. Clopidogrel 7.1.1.3. Ticagrelor 7.1.1.4. Prasugrel 7.1.1.5. Others 7.1.2. Market Key Findings, by Drug 7.1.2.1. Absolute $ Opportunity (2023 to 2033) 7.1.2.2. Market Share and BPS Analysis 7.1.2.3. Y-o-Y Growth Projections 7.1.2.4. Market Attractiveness Analysis 7.2. Global Market Regional Market Share Comparison, by Drug 8. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Distribution Channel 8.1. Introduction 8.1.1. Distribution Channel Definition 8.1.1.1. Hospital Pharmacies 8.1.1.2. Retail Pharmacies 8.1.1.3. Online Pharmacies 8.1.1.4. Others 8.1.2. Market Key Findings, by Distribution Channel 8.1.2.1. Absolute $ Opportunity (2023 to 2033) 8.1.2.2. Market Share and BPS Analysis 8.1.2.3. Y-o-Y Growth Projections 8.1.2.4. Market Attractiveness Analysis 8.2. Global Market Regional Market Share Comparison, by Distribution Channel 9. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Application 9.1. Introduction 9.1.1. Application Definition 9.1.1.1. Angioplasty 9.1.1.2. Percutaneous Coronary Interventions 9.1.1.3. Myocardial Infraction 9.1.1.4. Dental Surgeries 9.1.1.5. Arterial Thrombosis 9.1.2. Market Key Findings, by Application 9.1.2.1. Absolute $ Opportunity (2023 to 2033) 9.1.2.2. Market Share and BPS Analysis 9.1.2.3. Y-o-Y Growth Projections 9.1.2.4. Market Attractiveness Analysis 9.2. Global Market Regional Market Share Comparison, by Application 10. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by End User 10.1. Introduction 10.1.1. End User Definition 10.1.1.1. Ambulatory Surgical Centers 10.1.1.2. Hospitals 10.1.1.3. Emergency Service Centers 10.1.1.4. Clinics 10.1.2. Market Key Findings, by End User 10.1.2.1. Absolute $ Opportunity (2023 to 2033) 10.1.2.2. Market Share and BPS Analysis 10.1.2.3. Y-o-Y Growth Projections 10.1.2.4. Market Attractiveness Analysis 10.2. Global Market Regional Market Share Comparison, by End User 11. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Region 11.1. Introduction 11.1.1. Regional Coverage 11.1.1.1. North America 11.1.1.2. Europe 11.1.1.3. East Asia 11.1.1.4. South Asia 11.1.1.5. Latin America 11.1.1.6. Middle East & Africa (MEA) 11.1.1.7. Oceania 11.1.2. Market Key Findings, by Region 11.1.2.1. Absolute $ Opportunity (2023 to 2033) 11.1.2.2. Market Share and BPS Analysis 11.1.2.3. Y-o-Y Growth Projections 11.1.2.4. Market Attractiveness Analysis 11.2. Global Market Regional Market Share Comparison, by Region 12. North America Market Analysis and Forecast 12.1. Overview 12.1.1. North America Share in Global Market 12.2. Market Value & Volume Forecast and Analysis 12.2.1. By Country 12.2.1.1. United States 12.2.1.2. Canada 12.2.2. By Drug 12.2.3. By Distribution Channel 12.2.4. By Application 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.1.1. United States 12.3.1.2. Canada 12.3.2. By Drug 12.3.3. By Distribution Channel 12.3.4. By Application 12.3.5. By End User 12.4. Y-o-Y Growth Comparison 13. Europe Market Analysis and Forecast 13.1. Overview 13.1.1. Europe Share in Global Market 13.2. Market Value & Volume Forecast and Analysis 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. United Kingdom 13.2.1.3. France 13.2.1.4. Russia 13.2.1.5. Spain 13.2.1.6. Italy 13.2.1.7. Rest of Europe 13.2.2. By Drug 13.2.3. By Distribution Channel 13.2.4. By Application 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. United Kingdom 13.3.1.3. France 13.3.1.4. Russia 13.3.1.5. Spain 13.3.1.6. Italy 13.3.1.7. Rest of Europe 13.3.2. By Drug 13.3.3. By Distribution Channel 13.3.4. By Application 13.3.5. By End User 13.4. Y-o-Y Growth Comparison 14. East Asia Market Analysis and Forecast 14.1. Overview 14.1.1. East Asia Share in Global Market 14.2. Market Value & Volume Forecast and Analysis 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Drug 14.2.3. By Distribution Channel 14.2.4. By Application 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Drug 14.3.3. By Distribution Channel 14.3.4. By Application 14.3.5. By End User 14.4. Y-o-Y Growth Comparison 15. South Asia Market Analysis and Forecast 15.1. Overview 15.1.1. South Asia Share in Global Market 15.2. Market Value & Volume Forecast and Analysis 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Singapore 15.2.1.3. Indonesia 15.2.1.4. Thailand 15.2.1.5. Rest of South Asia 15.2.2. By Drug 15.2.3. By Distribution Channel 15.2.4. By Application 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Singapore 15.3.1.3. Indonesia 15.3.1.4. Thailand 15.3.1.5. Rest of South Asia 15.3.2. By Drug 15.3.3. By Distribution Channel 15.3.4. By Application 15.3.5. By End User 15.4. Y-o-Y Growth Comparison 16. Latin America Market Analysis and Forecast 16.1. Overview 16.1.1. Latin America Share in Global Market 16.2. Market Value & Volume Forecast and Analysis 16.2.1. By Country 16.2.1.1. Brazil 16.2.1.2. Mexico 16.2.1.3. Rest of LATAM 16.2.2. By Drug 16.2.3. By Distribution Channel 16.2.4. By Application 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.1.1. Brazil 16.3.1.2. Mexico 16.3.1.3. Rest of LATAM 16.3.2. By Drug 16.3.3. By Distribution Channel 16.3.4. By Application 16.3.5. By End User 16.4. Y-o-Y Growth Comparison 17. Middle East & Africa Market Analysis and Forecast 17.1. Overview 17.1.1. Middle East & Africa Share in Global Market 17.2. Market Value & Volume Forecast and Analysis 17.2.1. By Country 17.2.1.1. Turkey 17.2.1.2. GCC Countries 17.2.1.3. South Asia 17.2.1.4. Rest of MEA 17.2.2. By Drug 17.2.3. By Distribution Channel 17.2.4. By Application 17.2.5. By End User 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.1.1. Turkey 17.3.1.2. GCC Countries 17.3.1.3. South Asia 17.3.1.4. Rest of MEA 17.3.2. By Drug 17.3.3. By Distribution Channel 17.3.4. By Application 17.3.5. By End User 17.4. Y-o-Y Growth Comparison 18. Oceania Market Analysis and Forecast 18.1. Overview 18.1.1. Oceania Share in Global Market 18.2. Market Value & Volume Forecast and Analysis 18.2.1. By Country 18.2.1.1. Australia 18.2.1.2. New Zealand 18.2.2. By Drug 18.2.3. By Distribution Channel 18.2.4. By Application 18.2.5. By End User 18.3. Market Attractiveness Analysis 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Drug 18.3.3. By Distribution Channel 18.3.4. By Application 18.3.5. By End User 18.4. Y-o-Y Growth Comparison 19. Global Market Analysis Key Countries 19.1. US 19.1.1. Share of North American Market 19.1.2. Market Share, by Drug, 2022 19.1.3. Market Share, by Distribution Channel, 2022 19.1.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.1.5. Market Share, by End User, 2022 19.2. Canada 19.2.1. Share of North American Market 19.2.2. Market Share, by Drug, 2022 19.2.3. Market Share, by Distribution Channel, 2022 19.2.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.2.5. Market Share, by End User, 2022 19.3. Germany 19.3.1. Share of European Market 19.3.2. Market Share, by Drug, 2022 19.3.3. Market Share, by Distribution Channel, 2022 19.3.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.3.5. Market Share, by End User, 2022 19.4. United Kingdom 19.4.1. Share of European Market 19.4.2. Market Share, by Drug, 2022 19.4.3. Market Share, by Distribution Channel, 2022 19.4.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.4.5. Market Share, by End User, 2022 19.5. France 19.5.1. Share of European Market 19.5.2. Market Share, by Drug, 2022 19.5.3. Market Share, by Distribution Channel, 2022 19.5.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.5.5. Market Share, by End User, 2022 19.6. Russia 19.6.1. Share of European Market 19.6.2. Market Share, by Drug, 2022 19.6.3. Market Share, by Distribution Channel, 2022 19.6.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.6.5. Market Share, by End User, 2022 19.7. Spain 19.7.1. Share of European Market 19.7.2. Market Share, by Drug, 2022 19.7.3. Market Share, by Distribution Channel, 2022 19.7.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.7.5. Market Share, by End User, 2022 19.8. Italy 19.8.1. Share of European Market 19.8.2. Market Share, by Drug, 2022 19.8.3. Market Share, by Distribution Channel, 2022 19.8.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.8.5. Market Share, by End User, 2022 19.9. China 19.9.1. Share of East Asian Market 19.9.2. Market Share, by Drug, 2022 19.9.3. Market Share, by Distribution Channel, 2022 19.9.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.9.5. Market Share, by End User, 2022 19.10. Japan 19.10.1. Share of East Asian Market 19.10.2. Market Share, by Drug, 2022 19.10.3. Market Share, by Distribution Channel, 2022 19.10.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.10.5. Market Share, by End User, 2022 19.11. South Korea 19.11.1. Share of East Asian Market 19.11.2. Market Share, by Drug, 2022 19.11.3. Market Share, by Distribution Channel, 2022 19.11.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.11.5. Market Share, by End User, 2022 19.12. India 19.12.1. Share of South Asian Market 19.12.2. Market Share, by Drug, 2022 19.12.3. Market Share, by Distribution Channel, 2022 19.12.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.12.5. Market Share, by End User, 2022 19.13. Singapore 19.13.1. Share of South Asian Market 19.13.2. Market Share, by Drug, 2022 19.13.3. Market Share, by Distribution Channel, 2022 19.13.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.13.5. Market Share, by End User, 2022 19.14. Indonesia 19.14.1. Share of South Asian Market 19.14.2. Market Share, by Drug, 2022 19.14.3. Market Share, by Distribution Channel, 2022 19.14.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.14.5. Market Share, by End User, 2022 19.15. Thailand 19.15.1. Share of South Asian Market 19.15.2. Market Share, by Drug, 2022 19.15.3. Market Share, by Distribution Channel, 2022 19.15.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.15.5. Market Share, by End User, 2022 19.16. Brazil 19.16.1. Share of Latin American Market 19.16.2. Market Share, by Drug, 2022 19.16.3. Market Share, by Distribution Channel, 2022 19.16.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.16.5. Market Share, by End User, 2022 19.17. Mexico 19.17.1. Share of Latin American Market 19.17.2. Market Share, by Drug, 2022 19.17.3. Market Share, by Distribution Channel, 2022 19.17.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.17.5. Market Share, by End User, 2022 19.18. Turkey 19.18.1. Share of MEA Market 19.18.2. Market Share, by Drug, 2022 19.18.3. Market Share, by Distribution Channel, 2022 19.18.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.18.5. Market Share, by End User, 2022 19.19. GCC Countries 19.19.1. Share of MEA Market 19.19.2. Market Share, by Drug, 2022 19.19.3. Market Share, by Distribution Channel, 2022 19.19.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.19.5. Market Share, by End User, 2022 19.20. South Africa 19.20.1. Share of MEA Market 19.20.2. Market Share, by Drug, 2022 19.20.3. Market Share, by Distribution Channel, 2022 19.20.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.20.5. Market Share, by End User, 2022 19.21. Australia 19.21.1. Share of Oceania Market 19.21.2. Market Share, by Drug, 2022 19.21.3. Market Share, by Distribution Channel, 2022 19.21.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.21.5. Market Share, by End User, 2022 19.22. New Zealand 19.22.1. Share of Oceania Market 19.22.2. Market Share, by Drug, 2022 19.22.3. Market Share, by Distribution Channel, 2022 19.22.4. Market Value (US$ Mn) and Forecast 2023 to 2033 19.22.5. Market Share, by End User, 2022 20. Competition Landscape 20.1. Global Market Competition Dashboard 20.2. Global Market Tier Structure 20.2.1. Market Structure in 2022 20.2.2. Anticipated Market Structure in 2033 20.3. Global Market Share Analysis 21. Competition Analysis 21.1. Aspen 21.1.1. Company Overview 21.1.2. Distribution Channel Portfolio 21.1.3. Key Strategies 21.1.4. Regional Presence 21.1.5. Key Developments 21.1.6. SWOT Analysis 21.2. The Medicines Company 21.2.1. Company Overview 21.2.2. Distribution Channel Portfolio 21.2.3. Key Strategies 21.2.4. Regional Presence 21.2.5. Key Developments 21.2.6. SWOT Analysis 21.3. Sanofi 21.3.1. Company Overview 21.3.2. Distribution Channel Portfolio 21.3.3. Key Strategies 21.3.4. Regional Presence 21.3.5. Key Developments 21.3.6. SWOT Analysis 21.4. Pfizer 21.4.1. Company Overview 21.4.2. Distribution Channel Portfolio 21.4.3. Key Strategies 21.4.4. Regional Presence 21.4.5. Key Developments 21.4.6. SWOT Analysis 21.5. Johnson & Johnson 21.5.1. Company Overview 21.5.2. Distribution Channel Portfolio 21.5.3. Key Strategies 21.5.4. Regional Presence 21.5.5. Key Developments 21.5.6. SWOT Analysis 21.6. Daiichi Sankyo 21.6.1. Company Overview 21.6.2. Distribution Channel Portfolio 21.6.3. Key Strategies 21.6.4. Regional Presence 21.6.5. Key Developments 21.6.6. SWOT Analysis 21.7. Bristol-Myers Squibb 21.7.1. Company Overview 21.7.2. Distribution Channel Portfolio 21.7.3. Key Strategies 21.7.4. Regional Presence 21.7.5. Key Developments 21.7.6. SWOT Analysis 21.8. Otsuka 21.8.1. Company Overview 21.8.2. Distribution Channel Portfolio 21.8.3. Key Strategies 21.8.4. Regional Presence 21.8.5. Key Developments 21.8.6. SWOT Analysis 22. Appendix 23. Definitions of Analytical Frameworks 24. Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Drug, 2018 to 2033
Table 02: Global Market Value (US$ Mn), by Drug, 2018 to 2033
Table 03: Global Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 04: Global Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 05: Global Market Volume (Units), by Application, 2018 to 2033
Table 06: Global Market Value (US$ Mn), by Application, 2018 to 2033
Table 07: Global Market Volume (Units), by End User, 2018 to 2033
Table 08: Global Market Value (US$ Mn), by End User, 2018 to 2033
Table 09: Global Market Volume (Units), by Region, 2018 to 2033
Table 10: Global Market Value (US$ Mn), by Region, 2018 to 2033
Table 11: North America Market Volume (Units), by Drug, 2018 to 2033
Table 12: North America Market Value (US$ Mn), by Drug, 2018 to 2033
Table 13: North America Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 14: North America Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 15: North America Market Volume (Units), by Application, 2018 to 2033
Table 16: North America Market Value (US$ Mn), by Application, 2018 to 2033
Table 17: North America Market Volume (Units), by End User, 2018 to 2033
Table 18: North America Market Value (US$ Mn), by End User, 2018 to 2033
Table 19: North America Market Volume (Units), by Country, 2018 to 2033
Table 20: North America Market Value (US$ Mn), by Country, 2018 to 2033
Table 21: Europe Market Volume (Units), by Drug, 2018 to 2033
Table 22: Europe Market Value (US$ Mn), by Drug, 2018 to 2033
Table 23: Europe Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 24: Europe Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 25: Europe Market Volume (Units), by Application, 2018 to 2033
Table 26: Europe Market Value (US$ Mn), by Application, 2018 to 2033
Table 27: Europe Market Volume (Units), by End User, 2018 to 2033
Table 28: Europe Market Value (US$ Mn), by End User, 2018 to 2033
Table 29: Europe Market Volume (Units), by Country, 2018 to 2033
Table 30: Europe Market Value (US$ Mn), by Country, 2018 to 2033
Table 31: East Asia Market Volume (Units), by Drug, 2018 to 2033
Table 32: East Asia Market Value (US$ Mn), by Drug, 2018 to 2033
Table 33: East Asia Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 34: East Asia Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 35: East Asia Market Volume (Units), by Application, 2018 to 2033
Table 36: East Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 37: East Asia Market Volume (Units), by End User, 2018 to 2033
Table 38: East Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 39: East Asia Market Volume (Units), by Country, 2018 to 2033
Table 40: East Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 41: South Asia Market Volume (Units), by Drug, 2018 to 2033
Table 42: South Asia Market Value (US$ Mn), by Drug, 2018 to 2033
Table 43: South Asia Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 44: South Asia Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 45: South Asia Market Volume (Units), by Application, 2018 to 2033
Table 46: South Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 47: South Asia Market Volume (Units), by End User, 2018 to 2033
Table 48: South Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 49: South Asia Market Volume (Units), by Country, 2018 to 2033
Table 50: South Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 51: Latin America Market Volume (Units), by Drug, 2018 to 2033
Table 52: Latin America Market Value (US$ Mn), by Drug, 2018 to 2033
Table 53: Latin America Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 54: Latin America Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 55: Latin America Market Volume (Units), by Application, 2018 to 2033
Table 56: Latin America Market Value (US$ Mn), by Application, 2018 to 2033
Table 57: Latin America Market Volume (Units), by End User, 2018 to 2033
Table 58: Latin America Market Value (US$ Mn), by End User, 2018 to 2033
Table 59: Latin America Market Volume (Units), by Country, 2018 to 2033
Table 60: Latin America Market Value (US$ Mn), by Country, 2018 to 2033
Table 61: Middle East and Africa Market Volume (Units), by Drug, 2018 to 2033
Table 62: Middle East and Africa Market Value (US$ Mn), by Drug, 2018 to 2033
Table 63: Middle East and Africa Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 64: Middle East and Africa Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 65: Middle East and Africa Market Volume (Units), by Application, 2018 to 2033
Table 66: Middle East and Africa Market Value (US$ Mn), by Application, 2018 to 2033
Table 67: Middle East and Africa Market Volume (Units), by End User, 2018 to 2033
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2018 to 2033
Table 69: Middle East and Africa Market Volume (Units), by Country, 2018 to 2033
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2018 to 2033
Table 71: Oceania Market Volume (Units), by Drug, 2018 to 2033
Table 72: Oceania Market Value (US$ Mn), by Drug, 2018 to 2033
Table 73: Oceania Market Volume (Units), by Distribution Channel, 2018 to 2033
Table 74: Oceania Market Value (US$ Mn), by Distribution Channel, 2018 to 2033
Table 75: Oceania Market Volume (Units), by Application, 2018 to 2033
Table 76: Oceania Market Value (US$ Mn), by Application, 2018 to 2033
Table 77: Oceania Market Volume (Units), by End User, 2018 to 2033
Table 78: Oceania Market Value (US$ Mn), by End User, 2018 to 2033
Table 79: Oceania Market Volume (Units), by Country, 2018 to 2033
Table 80: Oceania Market Value (US$ Mn), by Country, 2018 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Fig 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2018 to 2033
Fig 02: Global Absolute $ Historical Market (2018 to 2022) and Absolute $ Opportunity (2023 to 2033), US$ Mn
Fig 03: Global Absolute Historical Volume Market (2018 to 2022) and Absolute Volume Opportunity (2023 to 2033), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Fig 05: Global Market Incremental $ Opportunity (US$ Thousand), 2023 to 2033
Fig 06: Global Market Share, By Drug – 2023 to 2033
Fig 07: Global Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 08: Global Market Attractiveness Index, By Drug – 2023 to 2033
Fig 09: Global Market Share, By Distribution Channel – 2023 to 2033
Fig 10: Global Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 11: Global Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 12: Global Market Share, By Application – 2023 to 2033
Fig 13: Global Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 14: Global Market Attractiveness Index, By Application – 2023 to 2033
Fig 15: Global Market Share, By End User – 2023 to 2033
Fig 16: Global Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 17: Global Market Attractiveness Index, By End User – 2023 to 2033
Fig 18: Global Market Share, by Region – 2023 to 2033
Fig 19: Global Market Y-o-Y Growth Projections, by Region – 2023 to 2033
Fig 20: Global Market Attractiveness Index, by Region – 2023 to 2033
Fig 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Drug – 2023 to 2033
Fig 24: North America Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 25: North America Market Attractiveness Index, By Drug – 2023 to 2033
Fig 26: North America Market Share, By Distribution Channel – 2023 to 2033
Fig 27: North America Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 28: North America Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 29: North America Market Share, By Application – 2023 to 2033
Fig 30: North America Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 31: North America Market Attractiveness Index, By Application – 2023 to 2033
Fig 32: North America Market Share, By End User – 2023 to 2033
Fig 33: North America Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 34: North America Market Attractiveness Index, By End User – 2023 to 2033
Fig 35: North America Market Share, By Country – 2023 to 2033
Fig 36: North America Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 37: North America Market Attractiveness Index, By Country – 2023 to 2033
Fig 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Drug – 2023 to 2033
Fig 41: Europe Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 42: Europe Market Attractiveness Index, By Drug – 2023 to 2033
Fig 43: Europe Market Share, By Distribution Channel – 2023 to 2033
Fig 44: Europe Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 45: Europe Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 46: Europe Market Share, By Application – 2023 to 2033
Fig 47: Europe Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 48: Europe Market Attractiveness Index, By Application – 2023 to 2033
Fig 49: Europe Market Share, By End User – 2023 to 2033
Fig 50: Europe Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 51: Europe Market Attractiveness Index, By End User – 2023 to 2033
Fig 52: Europe Market Share, By Country – 2023 to 2033
Fig 53: Europe Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 54: Europe Market Attractiveness Index, By Country – 2023 to 2033
Fig 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Drug – 2023 to 2033
Fig 58: East Asia Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 59: East Asia Market Attractiveness Index, By Drug – 2023 to 2033
Fig 60: East Asia Market Share, By Distribution Channel – 2023 to 2033
Fig 61: East Asia Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 62: East Asia Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 63: East Asia Market Share, By Application – 2023 to 2033
Fig 64: East Asia Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 65: East Asia Market Attractiveness Index, By Application – 2023 to 2033
Fig 66: East Asia Market Share, By End User – 2023 to 2033
Fig 67: East Asia Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 68: East Asia Market Attractiveness Index, By End User – 2023 to 2033
Fig 69: East Asia Market Share, By Country – 2023 to 2033
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 71: East Asia Market Attractiveness Index, By Country – 2023 to 2033
Fig 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Drug – 2023 to 2033
Fig 75: South Asia Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 76: South Asia Market Attractiveness Index, By Drug – 2023 to 2033
Fig 77: South Asia Market Share, By Distribution Channel – 2023 to 2033
Fig 78: South Asia Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 79: South Asia Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 80: South Asia Market Share, By Application – 2023 to 2033
Fig 81: South Asia Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 82: South Asia Market Attractiveness Index, By Application – 2023 to 2033
Fig 83: South Asia Market Share, By End User – 2023 to 2033
Fig 84: South Asia Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 85: South Asia Market Attractiveness Index, By End User – 2023 to 2033
Fig 86: South Asia Market Share, By Country – 2023 to 2033
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 88: South Asia Market Attractiveness Index, By Country – 2023 to 2033
Fig 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Drug – 2023 to 2033
Fig 92: Latin America Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 93: Latin America Market Attractiveness Index, By Drug – 2023 to 2033
Fig 94: Latin America Market Share, By Distribution Channel – 2023 to 2033
Fig 95: Latin America Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 96: Latin America Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 97: Latin America Market Share, By Application – 2023 to 2033
Fig 98: Latin America Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 99: Latin America Market Attractiveness Index, By Application – 2023 to 2033
Fig 100: Latin America Market Share, By End User – 2023 to 2033
Fig 101: Latin America Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 102: Latin America Market Attractiveness Index, By End User – 2023 to 2033
Fig 103: Latin America Market Share, By Country – 2023 to 2033
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 105: Latin America Market Attractiveness Index, By Country – 2023 to 2033
Fig 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Drug – 2023 to 2033
Fig 109: MEA Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 110: MEA Market Attractiveness Index, By Drug – 2023 to 2033
Fig 111: MEA Market Share, By Distribution Channel – 2023 to 2033
Fig 112: MEA Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 113: MEA Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 114: MEA Market Share, By Application – 2023 to 2033
Fig 115: MEA Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 116: MEA Market Attractiveness Index, By Application – 2023 to 2033
Fig 117: MEA Market Share, By End User – 2023 to 2033
Fig 118: MEA Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 119: MEA Market Attractiveness Index, By End User – 2023 to 2033
Fig 120: MEA Market Share, By Country – 2023 to 2033
Fig 121: MEA Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 122: MEA Market Attractiveness Index, By Country – 2023 to 2033
Fig 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Drug – 2023 to 2033
Fig 126: Oceania Market Y-o-Y Growth Projections, By Drug – 2023 to 2033
Fig 127: Oceania Market Attractiveness Index, By Drug – 2023 to 2033
Fig 128: Oceania Market Share, By Distribution Channel – 2023 to 2033
Fig 129: Oceania Market Y-o-Y Growth Projections, By Distribution Channel – 2023 to 2033
Fig 130: Oceania Market Attractiveness Index, By Distribution Channel – 2023 to 2033
Fig 131: Oceania Market Share, By Application – 2023 to 2033
Fig 132: Oceania Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 133: Oceania Market Attractiveness Index, By Application – 2023 to 2033
Fig 134: Oceania Market Share, By End User – 2023 to 2033
Fig 135: Oceania Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 136: Oceania Market Attractiveness Index, By End User – 2023 to 2033
Fig 137: Oceania Market Share, By Country – 2023 to 2033
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 139: Oceania Market Attractiveness Index, By Country – 2023 to 2033
Fig 140: United States Market share by Drug, 2022
Fig 141: United States Market share by Distribution Channel, 2022
Fig 142: United States Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 143: United States Market Share by End User, 2022
Fig 144: Canada Market share by Drug, 2022
Fig 145: Canada Market share by Distribution Channel, 2022
Fig 146: Canada Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 147: Canada Market Share by End User, 2022
Fig 148: Germany Market share by Drug, 2022
Fig 149: Germany Market share by Distribution Channel, 2022
Fig 150: Germany Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 151: Germany Market Share by End User, 2022
Fig 152: United Kingdom Market share by Drug, 2022
Fig 153: United Kingdom Market share by Distribution Channel, 2022
Fig 154: United Kingdom Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 155: United Kingdom Market Share by End User, 2022
Fig 156: France Market share by Drug, 2022
Fig 157: France Market share by Distribution Channel, 2022
Fig 158: France Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 159: France Market Share by End User, 2022
Fig 160: Russia Market share by Drug, 2022
Fig 161: Russia Market share by Distribution Channel, 2022
Fig 162: Russia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 163: Russia Market Share by End User, 2022
Fig 164: Spain Market share by Drug, 2022
Fig 165: Spain Market share by Distribution Channel, 2022
Fig 166: Spain Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 167: Spain Market Share by End User, 2022
Fig 168: Italy Market share by Drug, 2022
Fig 169: Italy Market share by Distribution Channel, 2022
Fig 170: Italy Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 171: Italy Market Share by End User, 2022
Fig 172: China Market share by Drug, 2022
Fig 173: China Market share by Distribution Channel, 2022
Fig 174: China Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 175: China Market Share by End User, 2022
Fig 176: Japan Market share by Drug, 2022
Fig 177: Japan Market share by Distribution Channel, 2022
Fig 178: Japan Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 179: Japan Market Share by End User, 2022
Fig 180: South Korea Market share by Drug, 2022
Fig 181: South Korea Market share by Distribution Channel, 2022
Fig 182: South Korea Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 183: South Korea Market Share by End User, 2022
Fig 184: India Market share by Drug, 2022
Fig 185: India Market share by Distribution Channel, 2022
Fig 186: India Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 187: India Market Share by End User, 2022
Fig 188: Singapore Market share by Drug, 2022
Fig 189: Singapore Market share by Distribution Channel, 2022
Fig 190: Singapore Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 191: Singapore Market Share by End User, 2022
Fig 192: Indonesia Market share by Drug, 2022
Fig 193: Indonesia Market share by Distribution Channel, 2022
Fig 194: Indonesia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 195: Indonesia Market Share by End User, 2022
Fig 196: Thailand Market share by Drug, 2022
Fig 197: Thailand Market share by Distribution Channel, 2022
Fig 198: Thailand Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 199: Thailand Market Share by End User, 2022
Fig 200: Brazil Market share by Drug, 2022
Fig 201: Brazil Market share by Distribution Channel, 2022
Fig 202: Brazil Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 203: Brazil Market Share by End User, 2022
Fig 204: Mexico Market share by Drug, 2022
Fig 205: Mexico Market share by Distribution Channel, 2022
Fig 206: Mexico Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 207: Mexico Market Share by End User, 2022
Fig 208: Turkey Market share by Drug, 2022
Fig 209: Turkey Market share by Distribution Channel, 2022
Fig 210: Turkey Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 211: Turkey Market Share by End User, 2022
Fig 212: GCC Countries Market share by Drug, 2022
Fig 213: GCC Countries Market share by Distribution Channel, 2022
Fig 214: GCC Countries Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 215: GCC Countries Market Share by End User, 2022
Fig 216: South Africa Market share by Drug, 2022
Fig 217: South Africa Market share by Distribution Channel, 2022
Fig 218: South Africa Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 219: South Africa Market Share by End User, 2022
Fig 220: Australia Market share by Drug, 2022
Fig 221: Australia Market share by Distribution Channel, 2022
Fig 222: Australia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 223: Australia Market Share by End User, 2022
Fig 224: New Zealand Market share by Drug, 2022
Fig 225: New Zealand Market share by Distribution Channel, 2022
Fig 226: New Zealand Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 227: New Zealand Market Share by End User, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the global anti-platelet agents market size in 2023?
In 2023, the market for anti-platelet agents is valued at US$ 2.4 billion.
What is the anticipated CAGR for anti-platelet agents during the forecast period?
The global anti-platelet agents market is forecasted to expand at a CAGR of 7% during the forecast period of 2023 to 2033.
How is the Canadian anti-platelet agents market estimated to fare?
Sales of anti-platelet agents in Canada are anticipated to increase at a CAGR of 6.2% from 2023 to 2033.
What is the forecasted value for anti-platelet agents in 2033?
The anti-platelet agents market is expected to reach a valuation of US$ 4.8 billion by 2033-end.
At what rate will anti-platelet agent demand increase in Germany?
Demand for anti-platelet agents in Germany is predicted to advance at a CAGR of 4.4%.
Who are the key providers of anti-platelet agents globally?
Prominent manufacturers of anti-platelet agents are Aspen, The Medicines Company, Sanofi, Pfizer, Johnson & Johnson, Daiichi Sankyo, Bristol-Myers Squibb, and Otsuka.
Anti-Platelet Agents Market